Newsroom 2010

2010 Releases

Company Statement - Shelf Life Reduction of Panvax® Junior
Ongoing monitoring by both CSL and the TGA of CSL’s Panvax® Junior vaccine has shown a decline in its potency and as a result a 12 month shelf life can no longer be supported. Panvax® Junior is the paediatric presentation of CSL’s 2009 H1N1 (pandemic) influenza vaccine, which is supplied in a single 0.25ml pre-filled syringe. More.

Update on Seasonal Influenza Vaccination of Children
CSL Limited (CSL) supports the statement made today by the Commonwealth Chief Medical Officer regarding seasonal flu vaccine for young children. More.

CSL Announces New Biotech Facility
CSL Limited today announced a major biotechnology project at CSL’s manufacturing site in Broadmeadows, Australia. The centrepiece of the project will be the creation of Victoria’s first large scale biotechnology facility for the late stage development of new therapies for cancer, bleeding disorders, inflammation and infection. More.

Update on Seasonal Influenza Vaccination of Young Children
CSL Biotherapies (CSL) today notes the Chief Medical Officer’s statement and updated recommendations regarding influenza vaccination for children under 5. More.

Seasonal influenza vaccine – paediatric adverse events
CSL Biotherapies is aware of reports of a number of adverse events following influenza vaccination of children. CSL is one of several suppliers of influenza vaccine in Australia. More.

CSL subsidiary Marks World Hemophilia Day with Factor IX Donation to World Federation of Hemophilia
Hemophilia B patients in the developing world will benefit from a recent donation of 1 million international units (IU) of factor IX medication made by CSL Behring to the World Federation of Hemophilia (WFH). More.

CSL Limited publishes first Corporate Responsibility Report
CSL Limited (ASX:CSL), Australia’s leading biopharmaceutical company, has released its first Corporate Responsibility Report, combining information about the Company’s economic, social and environmental performance for 2009. More.

© 2017 CSL Limited